CoChat
Sign Up
Cited by 241

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial

Saberi, Sara, Wheeler, Matthew, Bragg-Gresham, Jennifer, Hornsby, Whitney, Agarwal, Prachi P., Attili, Anil, Concannon, Maryann, Dries, Annika M., Shmargad, Yael, Salisbury, Heidi, Kumar, Suwen, Herrera, Jonathan J., Myers, Jonathan, Helms, Adam S., Ashley, Euan A., Day, Sharlene M.·2017·JAMA
DOI 10.1001/jama.2017.2503
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2017.2503

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • After 16 weeks, the 67 participants randomized to moderate intensity training showed improved exercise capacity with higher peak VO2 compared with the usual activity group (n=69), with a between group difference of 1.27 (95% confidence interval 0.17 to 2.37; P=0.02), as well as subjective improvement, with no arrhythmic events.

    “After 16 weeks, the 67 participants randomized to the moderate intensity training showed improved exercise capacity with higher peak VO 2 compared with the usual activity group (n=69), with a between group difference of 1.27 (95% confidence interval 0.17 to 2.37; P=0.02), as well as subjective improvement, with no arrhythmic events.”

    From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [130]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. [1]Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249-1254. [DOI] [PubMed] [Google Scholar]
  2. [2]Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol. 2008;19(1):104-110. [DOI] [PubMed] [Google Scholar]
  3. [3]Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis, I: a description of the disease based upon an analysis of 64 patients. Circulation. 1964;30(suppl 4):3-119. [DOI] [PubMed] [Google Scholar]
  4. [4]Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA. 1999;281(7):650-655. [DOI] [PubMed] [Google Scholar]
  5. [5]Gersh BJ, Maron BJ, Bonow RO, et al. ; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons . 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(24):2761-2796. [DOI] [PubMed] [Google Scholar]
  6. [6]Maron BJ, Udelson JE, Bonow RO, et al. ; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology . Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273-e280. [DOI] [PubMed] [Google Scholar]
  7. [7]Pelliccia A, Corrado D, Bjørnstad HH, et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil. 2006;13(6):876-885. [DOI] [PubMed] [Google Scholar]
  8. [9]Reineck E, Rolston B, Bragg-Gresham JL, et al. Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy. Am J Cardiol. 2013;111(7):1034-1039. [DOI] [PubMed] [Google Scholar]
  9. [10]Kokkinos P, Myers J, Kokkinos JP, et al. Exercise capacity and mortality in black and white men. Circulation. 2008;117(5):614-622. [DOI] [PubMed] [Google Scholar]
  10. [12]Sattelmair J, Pertman J, Ding EL, Kohl HW III, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation. 2011;124(7):789-795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. [13]Sofi F, Capalbo A, Cesari F, Abbate R, Gensini GF. Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15(3):247-257. [DOI] [PubMed] [Google Scholar]
  12. [15]O’Connor CM, Whellan DJ, Lee KL, et al. ; HF-ACTION Investigators . Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439-1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. [16]Pandey A, Parashar A, Kumbhani DJ, et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail. 2015;8(1):33-40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. [17]Sharma S, Firoozi S, McKenna WJ. Value of exercise testing in assessing clinical state and prognosis in hypertrophic cardiomyopathy. Cardiol Rev. 2001;9(2):70-76. [DOI] [PubMed] [Google Scholar]
  15. [18]Huff CM, Turer AT, Wang A. Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy. Qual Life Res. 2013;22(3):647-652. [DOI] [PubMed] [Google Scholar]
  16. [20]Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33(7):2044-2051. [DOI] [PubMed] [Google Scholar]
  17. [21]Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation. 1997;96(9):2987-2991. [DOI] [PubMed] [Google Scholar]
  18. [22]Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-381. [PubMed] [Google Scholar]
  19. [23]Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575-1581. [DOI] [PubMed] [Google Scholar]
  20. [24]Le VV, Perez MV, Wheeler MT, Myers J, Schnittger I, Ashley EA. Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy. Am Heart J. 2009;158(3):e27-e34. [DOI] [PubMed] [Google Scholar]
  21. [26]Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation. 1992;85(6):2119-2131. [DOI] [PubMed] [Google Scholar]
  22. [27]Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol. 1995;25(6):1239-1249. [DOI] [PubMed] [Google Scholar]
  23. [28]Vromen T, Kraal JJ, Kuiper J, Spee RF, Peek N, Kemps HM. The influence of training characteristics on the effect of aerobic exercise training in patients with chronic heart failure: a meta-regression analysis. Int J Cardiol. 2016;208:120-127. [DOI] [PubMed] [Google Scholar]
  24. [29]Swank AM, Horton J, Fleg JL, et al. ; HF-ACTION Investigators . Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circ Heart Fail. 2012;5(5):579-585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. [30]Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378(9798):1244-1253. [DOI] [PubMed] [Google Scholar]
  26. [31]Sweeting J, Ingles J, Ball K, Semsarian C. Challenges of exercise recommendations and sports participation in genetic heart disease patients. Circ Cardiovasc Genet. 2015;8(1):178-186. [DOI] [PubMed] [Google Scholar]
  27. [32]Klempfner R, Kamerman T, Schwammenthal E, et al. Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center. Eur J Prev Cardiol. 2015;22(1):13-19. [DOI] [PubMed] [Google Scholar]
  28. [33]Coats CJ, Rantell K, Bartnik A, et al. Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy. Circ Heart Fail. 2015;8(6):1022-1031. [DOI] [PubMed] [Google Scholar]
  29. [34]Finocchiaro G, Haddad F, Knowles JW, et al. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. JACC Heart Fail. 2015;3(5):408-418. [DOI] [PubMed] [Google Scholar]
  30. [35]Sorajja P, Allison T, Hayes C, Nishimura RA, Lam CS, Ommen SR. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2012;109(10):1494-1498. [DOI] [PubMed] [Google Scholar]
  31. [36]Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130(6):484-495. [DOI] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Metadata

Authors
Saberi, S., Wheeler, M., Bragg-Gresham, J., Hornsby, W., Agarwal, P. P., Attili, A., Concannon, M., Dries, A. M., Shmargad, Y., Salisbury, H., Kumar, S., Herrera, J. J., Myers, J., Helms, A. S., Ashley, E. A., & Day, S. M.
Venue
JAMA
Publisher
American Medical Association (AMA)
Published
2017-04-04
Volume
317
Issue
13
Pages
1349
ISSN
0098-7484
DOI
10.1001/jama.2017.2503
Cited by
241
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review